114 TIP: Jim Rickards & The Road to Ruin (Part 2)

Videos
Preston and Stig conduct their second part interview with New York Times Best Selling Author, James Rickards. Jim has a new book titled, The Road To Ruin, where he writes about the potential risks in the current financial markets. Tune in to hear about insider conversations with Ben Bernanke and William Dudley at the US Federal Reserve.

Rickards is a veteran of Wall Street with 35 years of experience and has had his fair share of chaotic experiences. For example, in 1998 he was the principal negotiator with the Federal Reserve Bank of New York for the bailout of Long-Term Capital Management (LTCM). Jim takes those extreme experiences and unique vantage points to talk about how the global economy is positioned today and where cracks in the system are starting to appear.

IN THIS EPISODE, YOU’LL LEARN:
– What central bankers are missing when looking at monetary policy
– What’s going to happen with interest rates in December
– World Taxation and how it could happen
– World taxation and how it could happen
– What Ben Bernanke and William Dudley personally told Jim about raising rates

Subscribe to the We Study Billionaires podcast show: https://link.chtbl.com/WSB

To access our show notes, courses, or forums, go to https://www.theinvestorspodcast.com/we-study-billionaires
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
ADDITIONAL INVESTING RESOURCES:

Intrinsic Value Assessments:

Investing Explained:

We Study Billionaires:

Bitcoin Fundamentals:

Millennial Investing:

Real Estate 101:

Asset Allocation Course:

? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
Download Stig & Preston’s 1-page checklist for finding great stock picks: https://www.theinvestorspodcast.com/form-youtube-checklist

Have a question? Get your voice heard on the show: https://www.theinvestorspodcast.com/your-questions
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
DISCLAIMER: This show is for entertainment purposes only. Before making any decisions consult a professional. This show is copyrighted by The Investor’s Podcast Network. Written permission must be granted before syndication or rebroadcasting.

Articles You May Like

Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
Behind the “Trump Bump”: How Much Could Stocks Rise in 2025?
AI’s Dark Horse Could Become Its Crown Jewel Under Trump
Hedge funds performed better under Democratic presidents than Republican ones, history shows
Top Wall Street analysts like these dividend-paying stocks